Cargando…

Why not consider an endothelin receptor antagonist against SARS‐CoV‐2?

Detalles Bibliográficos
Autores principales:	Javor, S., Salsano, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7194813/ https://www.ncbi.nlm.nih.gov/pubmed/32361169 http://dx.doi.org/10.1016/j.mehy.2020.109792

Ejemplares similares

Endothelin Receptors and Their Antagonists()()
por: Maguire, Janet J., et al.
Publicado: (2015)

Endothelin Receptor Antagonists in Kidney Disease
por: Martínez-Díaz, Irene, et al.
Publicado: (2023)

The Role of Endothelin-1 and Endothelin Receptor Antagonists in Inflammatory Response and Sepsis
por: Kowalczyk, Agata, et al.
Publicado: (2014)

Synergistic and Antagonistic Drug Combinations against SARS-CoV-2
por: Bobrowski, Tesia, et al.
Publicado: (2021)

Antidiuretic Effects of the Endothelin Receptor Antagonist Avosentan
por: Baltatu, Ovidiu Constantin, et al.
Publicado: (2012)

Iontophoresis of Endothelin Receptor Antagonists in Rats and Men
por: Roustit, Matthieu, et al.
Publicado: (2012)

Evidence for biased agonists and antagonists at the endothelin receptors
por: Maguire, Janet J.
Publicado: (2016)

Endothelin and Endothelin Antagonists in Chronic Kidney Disease
por: Kohan, Donald E., et al.
Publicado: (2014)

Devil's tools: SARS-CoV-2 antagonists against innate immunity
por: Xu, Duo, et al.
Publicado: (2021)

A surge of pediatric hepatitis: Why SARS-CoV-2 should be considered guilty until proven innocent
por: Nazir, Maheen, et al.
Publicado: (2022)

Endothelin antagonists: new bullets against lung injury?
por: Leeman, Marc
Publicado: (2005)

Vertical transmission of SARS-CoV-2: consider the denominator
por: Shook, Lydia L., et al.
Publicado: (2021)

The Origin of Sars-CoV-2: Why It Matters
por: Vineis, Paolo, et al.
Publicado: (2021)

Discovery of Synergistic and Antagonistic Drug Combinations against SARS-CoV-2 In Vitro
por: Bobrowski, Tesia, et al.
Publicado: (2020)

Clinical Pharmacokinetics and Pharmacodynamics of the Endothelin Receptor Antagonist Macitentan
por: Sidharta, P. N., et al.
Publicado: (2015)

The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro
por: Okamoto, Mika, et al.
Publicado: (2020)

VIP and endothelin receptor antagonist: An effective combination against experimental pulmonary arterial hypertension
por: Hamidi, Sayyed A, et al.
Publicado: (2011)

Forms of cholangitis to be considered after SARS-CoV-2 infection
por: Cho, Ju-Yeon, et al.
Publicado: (2022)

Why is the SARS-CoV-2 Omicron variant milder?
por: Xia, Bingqing, et al.
Publicado: (2022)

Clinical and hemodynamic effect of endothelin receptor antagonists in Eisenmenger Syndrome
por: Yonas, Emir, et al.
Publicado: (2020)

Endothelin receptor antagonist and airway dysfunction in pulmonary arterial hypertension
por: Droste, Annette S, et al.
Publicado: (2009)

Beyond Vasodilator: Anti-Apoptotic Effect of Endothelin Receptor Antagonist
por: Chang, Sung-A
Publicado: (2014)

The Endothelin Receptor Antagonist Macitentan Inhibits Human Cytomegalovirus Infection
por: Landázuri, Natalia, et al.
Publicado: (2021)

IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2
por: Bassiri, Hamid, et al.
Publicado: (2022)

The protective effect of endothelin receptor antagonists against surgically induced impairment of gastrointestinal motility in rats
por: Ługowska-Umer, Hanna, et al.
Publicado: (2019)

Interferon antagonists encoded by SARS-CoV-2 at a glance
por: Lee, Jung-Hyun, et al.
Publicado: (2022)

Computational screening of antagonists against the SARS-CoV-2 (COVID-19) coronavirus by molecular docking
por: Yu, Ran, et al.
Publicado: (2020)

What the neuroradiologist should additionally consider in SARS-CoV-2 infection
por: Finsterer, J., et al.
Publicado: (2020)

Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV
por: Aherfi, Sarah, et al.
Publicado: (2021)

Why do SARS-CoV-2 NSPs rush to the ER?
por: Santerre, Maryline, et al.
Publicado: (2020)

Sars-CoV-2 in pregnancy: Why is it better than expected?
por: Ghi, Tullio, et al.
Publicado: (2020)

Why is SARS-CoV-2 infection milder among children?
por: Palmeira, Patricia, et al.
Publicado: (2020)

Why Does SARS-CoV-2 Invade the Gastrointestinal Epithelium?
por: Uno, Yoshiharu
Publicado: (2020)

Why Are Physicists Involved in the Studies on the Origin of SARS-CoV-2?
por: Mehdizadeh, Ali Reza, et al.
Publicado: (2021)

Endothelin Receptor Antagonists: Status Quo and Future Perspectives for Targeted Therapy
por: Enevoldsen, Frederik C., et al.
Publicado: (2020)

Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells
por: Peduto Eberl, L, et al.
Publicado: (2003)

Optimizing endothelin receptor antagonist use in the management of pulmonary arterial hypertension
por: Steiner, M Kathryn, et al.
Publicado: (2008)

Macitentan: entry-into-humans study with a new endothelin receptor antagonist
por: Sidharta, Patricia N., et al.
Publicado: (2011)

Endothelin receptor antagonists in kidney protection for diabetic kidney disease and beyond?
por: Chung, Edmund Y. M., et al.
Publicado: (2022)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8jf204vt9hd65i1f30raos46ce